We are live on ! Find out more
INM icon

InMed Pharmaceuticals

9 hedge funds and large institutions have $206K invested in InMed Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

29% more funds holding

Funds holding: 79 (+2)

2.84% more ownership

Funds ownership: 8.1%10.94% (+2.8%)

14% less capital invested

Capital invested by funds: $241K → $206K (-$34.6K)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$142K +$17.6K +18,627 +9%
Citadel Advisors
2
Citadel Advisors
Florida
$30.3K +$44.3K +46,973 New
VF
3
Virtu Financial
New York
$13K +$18.8K +19,980 New
TSS
4
Two Sigma Securities
New York
$12.1K +$17.6K +18,718 New
UBS Group
5
UBS Group
Switzerland
$5.2K +$7.25K +7,691 +2,040%
PWMG
6
Private Wealth Management Group
New Jersey
$3.23K +$4.71K +5,000 New
SS
7
SBI Securities
Japan
$193
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
-$13.5K -12,753 Closed
Jane Street
10
Jane Street
New York
-$12.7K -11,978 Closed